Donor-reactive cytokine profiles after HLA-identical living-related kidney transplantation

Nephrology Dialysis Transplantation

Volumn 23, Issue 6, 2008, Pages 2016-2023

  Gerrits, Jeroen H ^a   Wetering, Jacqueline Van De ^a   Drabbels, Jos J M ^b   Claas, Frans H J ^b   Weimar, Willem ^a   Besouw, Nicole M Van ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alloreactivity; Elispot assay; IFN ; IL 10; Kidney transplantation; Minor histocompatibility antigens; Non HLA antigens

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 10; INTERLEUKIN 13;

ADULT; ALLOIMMUNITY; ARTICLE; CELL COUNT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GRAFT RECIPIENT; HLA MATCHING; HLA SYSTEM; HUMAN; HUMAN CELL; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRANZYMES; HISTOCOMPATIBILITY ANTIGENS; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-13; ISOANTIBODIES; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MONOCYTES; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TRANSPLANTATION IMMUNOLOGY;

EID: 44449179356     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm899     Document Type: Article

References (34)

1. Spierings E, Vermeulen CJ, Vogt MH et al. Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet 2003; 362: 610-615
2. Mutis T. Targeting alloreactive donor T-cells to hematopoietic system-restricted minor histocompatibility antigens to dissect graft-versus-leukemia effects from graft-versus-host disease after allogeneic stem cell transplantation. Int J Hematol 2003; 78: 208-212
3. Goulmy E. Human minor histocompatibility antigens. Curr Opin Immunol 1996; 8: 75-81
4. Opelz G. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005; 365: 1570-1576
5. Joosten SA, van Kooten C. Non-HLA humoral immunity and chronic kidney-graft loss. Lancet 2005; 365: 1522-1523
6. Lakkis FG. Role of cytokines in transplantation tolerance: lessons learned from gene-knockout mice. J Am Soc Nephrol 1998; 9: 2361-2367
7. Baan CC, Weimar W. Intragraft cytokine gene expression: implications for clinical transplantation. Transpl Int 1998; 11: 169-180
8. Spriewald B. Cytokines as mediators in immunologic tolerance. Curr Opin Org Transplant 2001; 6: 7-13
9. LeMoine A, Goldman M, Abramowicz D. Multiple pathways to allograft rejection. Transplantation 2002; 73: 1373-1381
10. Baan CC, van Emmerik NE, Balk AH et al. Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human heart transplants. Clin Exp Immunol 1994; 97: 293-298
11. LeMoine A, Goldman M. Non-classical pathways of cell-mediated allograft rejection: new challenges for tolerance induction? Am J Transplant 2003; 3: 101-106
12. Alberu J, Richaud-Patin Y, Vazquez-Lavista LG et al. In vivo IL-10 and TGF-beta production by PBMC from long-term kidney transplant recipients with excellent graft function: a possible feedback mechanism participating in immunological stability. Clin Transplant 2004; 18: 174-178
13. Petersen SL, Madsen HO, Ryder LP et al. Cytokine gene expression in peripheral blood mononuclear cells and alloreactivity in hematopoietic cell transplantation with nonmyeloablative conditioning. Biol Blood Marrow Transplant 2006; 12: 48-60
14. Weston LE, Geczy AF, Briscoe H. Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD. Bone Marrow Transplant 2006; 37: 207-212
15. Van Den Boogaardt DE, van Miert PP, de Vaal YJ et al. The ratio of interferon-gamma and interleukin-10 producing donor-specific cells as an in vitro monitoring tool for renal transplant patients. Transplantation 2006; 82: 844-848
16. Rocha PN, Plumb TJ, Crowley SD et al. Effector mechanisms in transplant rejection. Immunol Rev 2003; 196: 51-64
17. Ouwehand AJ, Baan CC, Roelen DL et al. The detection of cytotoxic T cells with high-affinity receptors for donor antigens in the transplanted heart as a prognostic factor for graft rejection. Transplantation 1993; 56: 1223-1229
18. van Besouw NM, Van Der Mast BJ, de Kuiper P et al. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Transplantation 2000; 70: 136-143
19. Scheibenbogen C, Romero P, Rivoltini L et al. Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial. J Immunol Methods 2000; 244: 81-89
20. Shafer-Weaver K, Sayers T, Strobl S et al. The granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity. J Transl Med 2003; 1: 14
21. Rininsland FH, Helms T, Asaad RJ et al. Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity. J Immunol Methods 2000; 240: 143-155
22. Spierings E, Drabbels J, Hendriks M et al. A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications. PLoS ONE 2006; 1: e42
23. Goulmy E. Minor histocompatibility antigens: from transplantation problems to therapy of cancer. Hum Immunol 2006; 67: 433-438
24. Simpson E, Scott D, James E et al. Minor H antigens: genes and peptides. Transpl Immunol 2002; 10: 115-123
25. Perez-Garcia A, De la Camara R, Torres A et al. Minor histocompatibility antigen HA-8 mismatch and clinical outcome after HLA-identical sibling donor allogeneic stem cell transplantation. Haematologica 2005; 90: 1723-1724
26. Bleakley M, Riddell SR. Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer 2004; 4: 371-380
27. Roncarolo MG, Gregori S, Battaglia M et al. Interleukin-10- secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006; 212: 28-50
28. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004; 10: 801-805
29. Battaglia M, Gianfrani C, Gregori S et al. IL-10-producing T regulatory type 1 cells and oral tolerance. Ann N Y Acad Sci 2004; 1029: 142-153
30. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 2000; 106: 145-155
31. Rodriguez DS, Jankowska-Gan E, Haynes LD et al. Immune regulation and graft survival in kidney transplant recipients are both enhanced by human leukocyte antigen matching. Am J Transplant 2004; 4: 537-543
32. Cai J, Lee J, Jankowska-Gan E et al. Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J Exp Med 2004; 199: 1017-1023
33. Salama AD, Najafian N, Clarkson MR et al. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 2003; 14: 1643-1651
34. Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007; 7: 585-598